Status: Not yet recruiting
QT Interval Effects Study of Oral FXS5626 Tablets
The purpose of this study is to evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc interval of a single oral dose of FXS5626 in healthy subjects.
Participants needed: 28
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Updated: Jul 10, 2026Locations: 1
Eligibility criteria
Healthy, adult, male or female,18-45 years of age (inclusive), with a Body Mass... [+14]